Home › Compare › ARCNF vs JNJ

ARCNF vs JNJ: Dividend Comparison 2026

ARCNF yields 100000.00% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ARCNF wins by $4.832206901976048e+26M in total portfolio value
10 years
ARCNF
ARCNF
● Live price
100000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.832206901976048e+26M
Annual income
$482,271,988,201,431,700,000,000,000,000,000.00
Full ARCNF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — ARCNF vs JNJ

📍 ARCNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodARCNFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ARCNF + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
ARCNF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ARCNF
Annual income on $10K today (after 15% tax)
$8,500,000.00/yr
After 10yr DRIP, annual income (after tax)
$409,931,189,971,216,900,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, ARCNF beats the other by $409,931,189,971,216,900,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ARCNF + JNJ for your $10,000?

ARCNF: 50%JNJ: 50%
100% JNJ50/50100% ARCNF
Portfolio after 10yr
$2.416103450988024e+26M
Annual income
$241,135,994,100,715,840,000,000,000,000,000.00/yr
Blended yield
99.80%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ARCNF
No analyst data
Altman Z
28.4
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ARCNF buys
0
JNJ buys
0
No recent congressional trades found for ARCNF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricARCNFJNJ
Forward yield100000.00% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$4.832206901976048e+26M$20.0K ✓
Annual income after 10y$482,271,988,201,431,700,000,000,000,000,000.00 ✓$827.78
Total dividends collected$4.8315851896727036e+26M$5.6K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ARCNF vs JNJ ($10,000, DRIP)

YearARCNF PortfolioARCNF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,010,700$10,000,000.00$10,676$355.77+$10.00M → ARCNF
2$9,366,505,842$9,355,794,392.52$11,407$389.39+$9366.49M → ARCNF
3$8,191,091,111,834$8,181,068,950,583.78$12,198$426.53+$8191091.10M → ARCNF
4$6,695,134,751,499,451$6,686,370,284,009,789.00$13,056$467.62+$6695134751.49M → ARCNF
5$5,114,850,040,116,031,000$5,107,686,245,931,928,000.00$13,987$513.12+$5114850040116.02M → ARCNF
6$3,652,290,278,277,141,000,000$3,646,817,388,734,216,400,000.00$14,998$563.56+$3652290278277141.00M → ARCNF
7$2,437,583,176,648,375,000,000,000$2,433,675,226,050,619,000,000,000.00$16,098$619.52+$2437583176648375296.00M → ARCNF
8$1,520,612,508,079,010,700,000,000,000$1,518,004,294,079,997,000,000,000,000.00$17,295$681.69+$1.5206125080790106e+21M → ARCNF
9$886,637,379,601,106,600,000,000,000,000$885,010,324,217,461,900,000,000,000,000.00$18,599$750.82+$8.866373796011065e+23M → ARCNF
10$483,220,690,197,604,800,000,000,000,000,000$482,271,988,201,431,700,000,000,000,000,000.00$20,022$827.78+$4.832206901976048e+26M → ARCNF

ARCNF vs JNJ: Complete Analysis 2026

ARCNF — Stock

Arcario AB, through its subsidiaries, operates a research-led digital asset brokerage with investment services in Sweden and internationally. It also offers interbank OTC market for digital currencies; and a bitcoin exchange, as well as provides bitcoin mining operations in northern Norway. The company was formerly known as Arcane Crypto AB and changed its name to Arcario AB in March 2023. Arcario AB is based in Stockholm, Sweden.

Full ARCNF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this ARCNF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ARCNF vs SCHDARCNF vs JEPIARCNF vs OARCNF vs KOARCNF vs MAINARCNF vs ABBVARCNF vs MRKARCNF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.